Intuitive Surgical Past Earnings Performance
Past criteria checks 5/6
Intuitive Surgical has been growing earnings at an average annual rate of 15.4%, while the Medical Equipment industry saw earnings growing at 13.3% annually. Revenues have been growing at an average rate of 14.4% per year. Intuitive Surgical's return on equity is 14.6%, and it has net margins of 28.5%.
Key information
15.38%
Earnings growth rate
15.23%
EPS growth rate
| Medical Equipment Industry Growth | 8.90% |
| Revenue growth rate | 14.35% |
| Return on equity | 14.63% |
| Net Margin | 28.51% |
| Last Earnings Update | 30 Jun 2025 |
Recent past performance updates
Recent updates
Intuitive Surgical: If You're Looking For A Dip To Buy, Get It Now (Rating Upgrade)
Jul 22Weekly Picks: 💊 VLS' Solvable Headwinds, VOS' Multi-Year Growth, and ISRG's Valuation Concerns
Jun 17
Unpleasant Surprises Could Be In Store For Intuitive Surgical, Inc.'s (NASDAQ:ISRG) Shares
Jun 16It Looks Like Shareholders Would Probably Approve Intuitive Surgical, Inc.'s (NASDAQ:ISRG) CEO Compensation Package
Apr 24Intuitive Surgical: Too Many Rain Clouds Coming
Apr 18Intuitive Surgical: Premium Valuation Meets Mounting Headwinds (Downgrade)
Apr 11
From Battle Field to Robotic Surgery
Intuitive Surgical (ISRG) is a pioneer in robotic-assisted surgery, revolutionizing the medical field with its da Vinci surgical system. Founded in 1995, the company has continuously innovated, making
Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth
Increased Adoption of Robotic Surgery:Hospitals and surgical centers continue to adopt Intuitive Surgical’s da Vinci systems as clinical evidence shows improved outcomes and reduced recovery times.ExpIntuitive Surgical: Getting Closed To Its Fair Value
Mar 09If EPS Growth Is Important To You, Intuitive Surgical (NASDAQ:ISRG) Presents An Opportunity
Mar 02Intuitive Surgical: The Robot Is Well-Oiled
Jan 28Intuitive Surgical: Second Half 2025 Guidance Is Critical To Maintaining Current Euphoria
Jan 20Intuitive Surgical (NASDAQ:ISRG) Hasn't Managed To Accelerate Its Returns
Jan 17Revenues Tell The Story For Intuitive Surgical, Inc. (NASDAQ:ISRG)
Dec 30Intuitive Surgical: Growing Impressively, But It Appears Overvalued
Dec 27Intuitive Surgical: One Of The Best Business Models In The World, But Not At This Price
Nov 14Intuitive Surgical Q3: Da Vinci 5 Robot Set For 2025, But Overvalued
Oct 18Intuitive Surgical (NASDAQ:ISRG) Is Reinvesting At Lower Rates Of Return
Oct 04Intuitive Surgical Offers Low Risk, High Return Despite Valuation Concerns
Sep 24What You Can Learn From Intuitive Surgical, Inc.'s (NASDAQ:ISRG) P/S
Sep 16Intuitive Surgical: Detached From Fundamentals
Aug 26
Da Vinci 5 Launch And Digital Expansion Set To Revolutionize Surgical Efficiency And Drive Growth
Launch of da Vinci 5 systems and expansion in digital services like My Intuitive app show promise for revenue growth and operational efficiency.Intuitive Surgical: A Lofty Price To Pay For Innovation, Wait For A Better Entry Point
Aug 20Intuitive Surgical: Shares Surge, But Now Near Fair Value (Rating Downgrade)
Jul 12Intuitive Surgical: Sell Signals Abound
May 17Intuitive Surgical: Growth And Margins Will Be Challenged In 2024
Apr 12Intuitive Surgical: Buy A 'Little Slice' Of The Future
Jan 29Intuitive Surgical: Strong Pre-Announced Q4 - Time To Harvest The Gain, Initiate With 'Sell'
Jan 13Revenue & Expenses Breakdown
How Intuitive Surgical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 25 | 9,145 | 2,608 | 2,227 | 1,210 |
| 31 Mar 25 | 8,715 | 2,476 | 2,191 | 1,177 |
| 31 Dec 24 | 8,352 | 2,323 | 2,119 | 1,145 |
| 30 Sep 24 | 7,867 | 2,243 | 2,095 | 1,111 |
| 30 Jun 24 | 7,573 | 2,094 | 2,036 | 1,074 |
| 31 Mar 24 | 7,319 | 1,988 | 1,975 | 1,038 |
| 31 Dec 23 | 7,124 | 1,798 | 1,964 | 999 |
| 30 Sep 23 | 6,851 | 1,517 | 1,863 | 983 |
| 30 Jun 23 | 6,665 | 1,425 | 1,847 | 951 |
| 31 Mar 23 | 6,431 | 1,312 | 1,801 | 913 |
| 31 Dec 22 | 6,222 | 1,322 | 1,712 | 879 |
| 30 Sep 22 | 6,118 | 1,378 | 1,673 | 818 |
| 30 Jun 22 | 5,964 | 1,435 | 1,600 | 767 |
| 31 Mar 22 | 5,906 | 1,644 | 1,532 | 722 |
| 31 Dec 21 | 5,710 | 1,705 | 1,467 | 671 |
| 30 Sep 21 | 5,489 | 1,689 | 1,370 | 637 |
| 30 Jun 21 | 5,163 | 1,623 | 1,305 | 627 |
| 31 Mar 21 | 4,551 | 1,173 | 1,234 | 608 |
| 31 Dec 20 | 4,358 | 1,061 | 1,216 | 595 |
| 30 Sep 20 | 4,307 | 1,053 | 1,227 | 602 |
| 30 Jun 20 | 4,358 | 1,136 | 1,220 | 583 |
| 31 Mar 20 | 4,604 | 1,386 | 1,213 | 560 |
| 31 Dec 19 | 4,479 | 1,379 | 1,178 | 557 |
| 30 Sep 19 | 4,247 | 1,314 | 1,121 | 521 |
| 30 Jun 19 | 4,040 | 1,210 | 1,053 | 492 |
| 31 Mar 19 | 3,850 | 1,147 | 998 | 467 |
| 31 Dec 18 | 3,724 | 1,128 | 941 | 418 |
| 30 Sep 18 | 3,570 | 804 | 876 | 385 |
| 30 Jun 18 | 3,457 | 810 | 847 | 361 |
| 31 Mar 18 | 3,306 | 778 | 820 | 351 |
| 31 Dec 17 | 3,138 | 671 | 811 | 329 |
| 30 Sep 17 | 3,003 | 906 | 762 | 311 |
| 30 Jun 17 | 2,878 | 819 | 736 | 290 |
| 31 Mar 17 | 2,790 | 780 | 712 | 260 |
| 31 Dec 16 | 2,707 | 738 | 692 | 240 |
| 30 Sep 16 | 2,619 | 722 | 666 | 223 |
| 30 Jun 16 | 2,522 | 678 | 653 | 212 |
| 31 Mar 16 | 2,434 | 628 | 643 | 206 |
| 31 Dec 15 | 2,367 | 589 | 627 | 197 |
| 30 Sep 15 | 2,285 | 546 | 621 | 192 |
| 30 Jun 15 | 2,250 | 502 | 620 | 189 |
| 31 Mar 15 | 2,179 | 472 | 615 | 179 |
| 31 Dec 14 | 2,132 | 419 | 609 | 178 |
| 30 Sep 14 | 2,082 | 438 | 602 | 172 |
Quality Earnings: ISRG has high quality earnings.
Growing Profit Margin: ISRG's current net profit margins (28.5%) are higher than last year (27.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ISRG's earnings have grown by 15.4% per year over the past 5 years.
Accelerating Growth: ISRG's earnings growth over the past year (24.5%) exceeds its 5-year average (15.4% per year).
Earnings vs Industry: ISRG earnings growth over the past year (24.5%) exceeded the Medical Equipment industry 11.2%.
Return on Equity
High ROE: ISRG's Return on Equity (14.6%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/08/01 16:22 |
| End of Day Share Price | 2025/08/01 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Intuitive Surgical, Inc. is covered by 62 analysts. 30 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| null null | Argus Research Company |
| Richard Purkiss | Atlantic Equities LLP |